TY - JOUR
T1 - Regulation of osteoclast differentiation and function by the CaMK-CREB pathway
AU - Sato, Kojiro
AU - Suematsu, Ayako
AU - Nakashima, Tomoki
AU - Takemoto-Kimura, Sayaka
AU - Aoki, Kazuhiro
AU - Morishita, Yasuyuki
AU - Asahara, Hiroshi
AU - Ohya, Keiichi
AU - Yamaguchi, Akira
AU - Takai, Toshiyuki
AU - Kodama, Tatsuhiko
AU - Chatila, Talal A.
AU - Bito, Haruhiko
AU - Takayanagi, Hiroshi
N1 - Funding Information:
We are grateful to M.A. Brown (Northwestern University Feinberg School of Medicine), T. Kitamura (Institute of Medical Science, University of Tokyo), R.A. Maurer (Oregon Health & Science University,), T. Miyakawa (Graduate School of Medicine, Kyoto University), N. Nozaki (Kanagawa Dental College), G.D. Roodman (University of Pittsburgh), M. Montminy (Salk Institute for Biological Studies), V. See (Université Louis Pasteur), C. Vinson (National Cancer Institute), Seikagaku Corporation and the RNAi Co. Ltd. for providing materials. We also thank J. Taka, Y. Suzuki, H. Murayama, H. Saito, M. Asagiri, M. Shinohara, T. Koga, H.J. Gober, T. Kunigami, Y. Kim, U. Sato and I. Takayanagi for technical assistance and discussion. This work was supported in part by the Solution Oriented Research for Science and Technology (SORST) program of the Japan Science and Technology Agency (JST); a Grant-in-Aid for Creative Scientific Research from the Japan Society for the Promotion of Science (JSPS); grants for the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); grants for the 21st Century Center of Excellence program from MEXT; Grants-in Aid for Scientific Research from MEXT; Health Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan; and grants from the Naito Foundation, Suzuken Memorial Foundation, Uehara Memorial Foundation, Kato Memorial Bioscience Foundation, Cell Science Research Foundation and the Nakatomi Foundation.
PY - 2006/12
Y1 - 2006/12
N2 - Calcium (Ca2+) signaling is essential for a variety of cellular responses and higher biological functions. Ca2+/calmodulin-dependent kinases (CaMKs) and the phosphatase calcineurin activate distinct downstream pathways that are mediated by the transcription factors cAMP response element (CRE)-binding protein (CREB) and nuclear factor of activated T cells (NFAT), respectively. The importance of the calcineurin-NFAT pathway in bone metabolism has been demonstrated in osteoclasts, osteoblasts and chondrocytes. However, the contribution of the CaMK-CREB pathway is poorly understood, partly because of the difficulty of dissecting the functions of homologous family members. Here we show that the CaMKIV-CREB pathway is crucial for osteoclast differentiation and function. Pharmacological inhibition of CaMKs as well as the genetic ablation of Camk4 reduced CREB phosphorylation and downregulated the expression of c-Fos, which is required for the induction of NFATc1 (the master transcription factor for osteoclastogenesis) that is activated by receptor activator of NF-κB ligand (RANKL). Furthermore, CREB together with NFATc1 induced the expression of specific genes expressed by differentiated osteoclasts. Thus, the CaMK-CREB pathway biphasically functions to regulate the transcriptional program of osteoclastic bone resorption, by not only enhancing induction of NFATc1 but also facilitating NFATc1-dependent gene regulation once its expression is induced. This provides a molecular basis for a new therapeutic strategy for bone diseases.
AB - Calcium (Ca2+) signaling is essential for a variety of cellular responses and higher biological functions. Ca2+/calmodulin-dependent kinases (CaMKs) and the phosphatase calcineurin activate distinct downstream pathways that are mediated by the transcription factors cAMP response element (CRE)-binding protein (CREB) and nuclear factor of activated T cells (NFAT), respectively. The importance of the calcineurin-NFAT pathway in bone metabolism has been demonstrated in osteoclasts, osteoblasts and chondrocytes. However, the contribution of the CaMK-CREB pathway is poorly understood, partly because of the difficulty of dissecting the functions of homologous family members. Here we show that the CaMKIV-CREB pathway is crucial for osteoclast differentiation and function. Pharmacological inhibition of CaMKs as well as the genetic ablation of Camk4 reduced CREB phosphorylation and downregulated the expression of c-Fos, which is required for the induction of NFATc1 (the master transcription factor for osteoclastogenesis) that is activated by receptor activator of NF-κB ligand (RANKL). Furthermore, CREB together with NFATc1 induced the expression of specific genes expressed by differentiated osteoclasts. Thus, the CaMK-CREB pathway biphasically functions to regulate the transcriptional program of osteoclastic bone resorption, by not only enhancing induction of NFATc1 but also facilitating NFATc1-dependent gene regulation once its expression is induced. This provides a molecular basis for a new therapeutic strategy for bone diseases.
UR - http://www.scopus.com/inward/record.url?scp=33845539490&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33845539490&partnerID=8YFLogxK
U2 - 10.1038/nm1515
DO - 10.1038/nm1515
M3 - Article
C2 - 17128269
AN - SCOPUS:33845539490
VL - 12
SP - 1410
EP - 1416
JO - Nature Medicine
JF - Nature Medicine
SN - 1078-8956
IS - 12
ER -